Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$209.01 - $232.56 $43,683 - $48,605
209 Added 11.36%
2,049 $447,000
Q4 2023

Feb 02, 2024

BUY
$197.69 - $227.29 $15,617 - $17,955
79 Added 4.49%
1,840 $418,000
Q3 2023

Nov 02, 2023

BUY
$201.05 - $221.7 $20,909 - $23,056
104 Added 6.28%
1,761 $354,000
Q2 2023

Jul 28, 2023

BUY
$211.93 - $241.33 $2,119 - $2,413
10 Added 0.61%
1,657 $399,000
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $1,919 - $2,320
9 Added 0.55%
1,647 $377,000
Q4 2022

Jan 26, 2023

SELL
$203.72 - $248.97 $228,981 - $279,842
-1,124 Reduced 40.7%
1,638 $0
Q3 2022

Nov 10, 2022

BUY
$204.81 - $262.19 $138,041 - $176,716
674 Added 32.28%
2,762 $566,000
Q2 2022

Aug 09, 2022

BUY
$213.86 - $277.87 $225,836 - $293,430
1,056 Added 102.33%
2,088 $489,000
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $33,776 - $38,763
130 Added 14.41%
1,032 $272,000
Q4 2021

Jan 26, 2022

SELL
$271.6 - $314.21 $46,986 - $54,358
-173 Reduced 16.09%
902 $283,000
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $64,857 - $72,768
236 Added 28.13%
1,075 $303,000
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $211,318 - $233,359
839 New
839 $231,000
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $217,377 - $270,586
-1,061 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $198,311 - $227,499
1,061 New
1,061 $216,000
Q3 2017

Oct 30, 2017

SELL
$149.47 - $160.56 $205,969 - $221,251
-1,378 Closed
0 $0
Q2 2017

Jan 11, 2018

SELL
N/A
-488 Reduced 26.15%
1,378 $212,000
Q1 2017

Jan 11, 2018

SELL
N/A
-623 Reduced 25.03%
1,866 $268,000
Q4 2016

Jan 11, 2018

SELL
N/A
-752 Reduced 23.2%
2,489 $320,000
Q3 2016

Jan 11, 2018

SELL
N/A
-382 Reduced 10.54%
3,241 $446,000
Q1 2016

Jan 11, 2018

BUY
N/A
3,623
3,623 $424,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.